Active and indolent chronic lymphocytic leukaemia - Immune and hormonal peculiarities

Cancer Immunology Immunotherapy

Volumn 45, Issue 2, 1997, Pages 109-114

  Everaus, Hele ^a   Luik, Ene ^a   Lehtmaa, Jane ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Active indolent; Chronic lymphocytic leukaemia; Endocrine hormones; Immune status

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CELLULAR IMMUNODEFICIENCY; CHRONIC LYMPHATIC LEUKEMIA; CORTICOTROPIN BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HUMAN; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; T LYMPHOCYTE;

ADULT; AGED; FEMALE; GONADAL STEROID HORMONES; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED;

EID: 0030663994     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050409     Document Type: Article

References (44)

1. Baldini L, Mozzana R, Cortelezzi A, Neri A, Radaelli F, Cesana B, Maiolo AT, Polli EE (1985) Prognostic significance of immuno-globuline phenotype in B cell chronic lymphocyte leukaemia. Blood 65:340
2. Bateman A, Singh A, Krai T, Solomon A (1989) The immune-hypothalamic-pituitary-adrenal axis. Endocrinol Rev 10:92
3. Berson SA, Yalow RS (1968) Radioimmunoassay of ACTH in plasma. J Clin Invest 47:2725
4. Besedovsky HO, Rey A del (1992) Immunoneuroendocrine circuits: integrative role of cytokines. Front Neuroendocrinol 13:61
5. Besedovsky HO, Sorokin E, Keller H, Miller I (1975) Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 150:466
6. Binet IL, Leporrcier M, Dighiero G, Charron D, D'Athis Ph, Vaugier G, Merle Beral H, Natali JC, Raphael M, Nizet B, Follezou JY (1977) A clinical staging system for chronic lymphocytic leukaemia. Prognostic significance. Cancer 40:855
7. Blalock IE (1989) A molecular basis for bi-directional communication between the immune and neuroendocrine systems. Physiol Rev 69:1
8. Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MM, Boldt DH, Kempin SI, Foon KA (1988) Guidelines for clinical protocols for chronic lymphocytic leukaemia: recommendations of the National Cancer Institute-Sponsored Working Group 29:152
9. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR (1996) National Cancer Institute-sponsored Working Group Guidelines for chronic lymphocytic leukaemia: revised guidelines for diagnosis and treatment 87:4990
10. Chronic Leukaemia Myeloma Task Force (1973) Proposed guidelines for protocol studies. III. Chronic lymphocytic leukaemia. Cancer Chemother Rep 4:159
11. Cohn DA (1979) High sensitivity to androgen as a contributing factor in sex differences in the immune response. Arthritis Rheum 22:1218
12. Collins RJ, Vershuer LA, Harmon BN, Prentice RL, Pope JH, Kerr JFR (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 71:343
13. Decker T, Flohr T, Trautmann P, Aman MJ, Holler W, Majdic O, Huber C, Peschel C (1995) Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukaemia Blood 86:1115
14. Del Rey A, Besedovsky HO, Sorkin E (1984) Endogenous blood levels of corticosterone control of the immunological cell mass and B cell activity in mice J Immunol 133:572
15. Eidinger D, Carrett TJ, (1992) Studies on the regulatory effects of the sex hormones on the antibody formation and stem cell differentiation. J Exp Med 136:1098
16. Elves MW, Roath S, Isrealis MC (1963) The response of lymphocytes to antigen challenge in vitro. Lancet 1:806
17. Everaus H (1984) Immunological aspects of chronic lymphocytic leukaemia. Dissertation, University of Tartu, Tartu, Estonia
18. Fernandes LA, MacSween IH, Langley GR (1981) Increased T-cell reactivity to leukemic B-cells in chronic lymphocytic leukaemia with change of stable disease to its progressive form. Haematology 10:137
19. Foa R, Catovsky D, Brozovic M, Marsh G, Oiyritangkumaran T, Cherchi M, Gallon DAG (1979) Clinical staging and immunological findings in chronic lymphocytic leukaemia. Cancer 44:483
20. Foon KA, Rai KR, Gale RP (1990) Chronic lymphocytic leukaemia new insights into biology and therapy. Ann Intern Med 113:525
21. Fuji H, Nawa Y, Tsuchiya H, Matsuno K, Fukomoto T, Fukuda S, Kotani M (1975) Effect of a single administration of testosterone on the immune response and lymphoid tissues in mice. Cell Immunol 20:315
22. Giovarelli M (1988) Release of interleukin-2 like material by B chronic lymphocytic leukaemia cells. An autocrine or paracrine model of production and utilization Leuk Res 12:201
23. Gronowiez E, Goutinho A (1975) Functional heterogeneity. Transplant Rev 24:3
24. Grossmann CJ (1984) Regulation of the immune system by sex steroids. Endocrinol Rev 5:435
25. Grossmann CJ (1985) Interactions between the gonadal steroids and the immune system. Science 227:257
26. Grossman CJ (1991) Immunopharmacology. In: Greenspan FS (ed) Basic and clinical endocrinology. Calif, p 40
27. Huang RW, Tsuda H, Takatsuki K (1993) Interleukin-2 prevents programmed cell death in chronic lymphocytic leukaemia cells. Int J Haematol 58:83
28. International Workshop on Chronic Lymphocytic Leukaemia. Chronic lymphocytic leukaemia: recommendations for diagnosis staging and response criteria. (1989) Ann Intern Med 110:236
29. Juliusson G (1981) Leukemic B-lymphocytic malignancy. A clinical immunological and cytogenetic study, utilizing mitogens to activate and differentiate malignant. Dissertation, Karolinska Institute Stockholm. Sweden, p 11
30. Korsmeyer SI, Greene WC, Cossman J, Hsu SM, Jensen JP, Neckers LM, Marshall SL, Bakhsi A, Depper JM Leonard WJ, Jaffe ES, Waldmann TA (1983) Rearrangement and expression of immunoglobulin genes and expression of TAC antigen in hairy cell leukaemia. Proc Natl Acad Sci USA 80: 3844
31. Lantz O, Grillot-Courvalin C, Schmitt C, Fermand J-P, Broyet J-C (1985). Interleukin 2 induced proliferation of leukemic human B cells. J Exp Med 161:1225
32. Litam P, Swan F, Cabanillas F, Tucker SL, McLauchlin P, Hagemeister FB, Rodriguez MA, Velasquez WS (1991) Prognostic value of serum beta-2 microglobulin in low grade lymphoma. Ann Intern Med 114:855
33. Mancini G, Carbonara AO, Heremans IF (1965) Immunochemical quantitation of antigens by single radial diffusion. Imniunochemistry 2:235
34. Morabito F, Callea I, Rodino A, Messina G, Gallea N, Iacopino P, Nobile F, Brugiatelli M (1995) Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukaemia. Leukaemia 9:1450
35. Nicholson GL (1976) Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta 458:1
36. Panayotides P, Lenkei R, Porwit A, Reizenstein P (1986) Malignant B-cells have receptors for and respond to interleukin-2. Med Oncol Tumor Pharmacother 3:255
37. Platsoucas CD, Galinski M, Kempin S, Reich L, Clarkson B, Good R (1982) Abnormal T-lymphocyte subpopulations in patients with B cell chronic lymphocytic leukaemia. An analysis by monoclonal antibodies. J Immunol 129:2305
38. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging chronic lymphocytic leukaemia 46:219
39. Rossi IF, Klein B, Commes T, Jourdan M (1985) Interleukin 2 production in B cell chronic lymphocytic leukaemia. Blood 66:840
40. Sachs L, Lotem I (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15
41. 2-M and acute phase reactants in chronic lymphocytic leukaemia. Acta Haematol 64:79
42. Taylor DS, Kern JA, Nowell PC (1986) IL-2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood. J Immunol 136:1620
43. de Totero D, Francia di Celle P, Cignetti A (1995) The IL-2 receptor complex: expression and function on normal and leukemic B cells. Leukemia 9: 1425
44. Warren L, Buck CA, Tuczynski GP (1978) Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behaviour. Biochim Biophys Acta 516:97